1,756 results on '"Bloomfield, Clara D."'
Search Results
2. Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
3. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
4. Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq
5. Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)
6. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A
7. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
8. Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)
9. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
10. Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia
11. Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations
12. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
13. Clinical and functional significance of circular RNAs in cytogenetically normal AML
14. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
15. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
16. Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years
17. Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement
18. A precision medicine classification for treatment of acute myeloid leukemia in older patients
19. Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21
20. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
21. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
22. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders
23. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study
24. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells
25. Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically
26. Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA
27. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
28. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
29. Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq
30. Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia
31. A Pilot Study of High-Throughput, Sequence-Based Mutational Profiling of Primary Human Acute Myeloid Leukemia Cell Genomes
32. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
33. Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia
34. BAALC, The Human Member of a Novel Mammalian Neuroectoderm Gene Lineage, is Implicated in Hematopoiesis and Acute Leukemia
35. Expression Profiling Reveals Fundamental Biological Differences in Acute Myeloid Leukemia with Isolated Trisomy 8 and Normal Cytogenetics
36. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia
37. Identification of a Gene at 11q23 Encoding a Guanine Nucleotide Exchange Factor: Evidence for Its Fusion with MLL in Acute Myeloid Leukemia
38. Chromosome Abnormalities in Acute Myeloid Leukaemia and Their Clinical Importance
39. The Partial Tandem Duplication of ALL1 (MLL) is Consistently Generated by Alu-Mediated Homologous Recombination in Acute Myeloid Leukemia
40. Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
41. Data from Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia
42. Data from Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
43. Supplementary Table S2 from Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
44. Supplementary Methods; Supplementary Tables S1, S3; and Supplementary Figures S1-S2 from Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
45. Supplementary Tables 1 - 4, Figures 1 - 6 from Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia
46. Supplementary Materials from Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality
47. Supplementary Table S4 from Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia
48. Data from Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality
49. Supplementary Data from Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia
50. Supplementary Data from EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.